<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01696825</url>
  </required_header>
  <id_info>
    <org_study_id>2012-182</org_study_id>
    <nct_id>NCT01696825</nct_id>
  </id_info>
  <brief_title>Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems</brief_title>
  <official_title>COMPARISON OF ABSORPTION OF VAGINAL DIAZEPAM USING DIFFERENT DELIVERY SYSTEMS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jason Gilleran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>William Beaumont Hospitals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine which of three delivery systems of vaginal diazepam
      have the best systemic absorption, measured by serum diazepam levels. The three delivery
      systems are: moistened tablet, suppository or cream. Additionally the study will compare the
      side effects and absorption of vaginal diazepam with oral diazepam. Vaginal diazepam is used
      off-label vaginally to relax pelvic floor muscles and reduce pelvic pain caused from pelvic
      floor dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum diazepam levels measured over time</measure>
    <time_frame>Baseline then 2 hours, 4 hours and 8 hours post-medication administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects observed with each of three types of vaginal diazepam</measure>
    <time_frame>Baseline and 2 hours, 4 hours and 8 hours post medication administration</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Metabolism, Drug</condition>
  <arm_group>
    <arm_group_label>Diazepam Tablet, 5 mg, Vaginal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diazepam Suppository, 5 mg, Vaginal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diazepam Cream, 5 mg, Vaginal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diazepam Tablet, 5 Mg, Oral</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam tablet, 5 mg, vaginal</intervention_name>
    <description>Diazepam tablet, 5 mg, moistened and inserted vaginally</description>
    <arm_group_label>Diazepam Tablet, 5 mg, Vaginal</arm_group_label>
    <arm_group_label>Diazepam Tablet, 5 Mg, Oral</arm_group_label>
    <other_name>Valium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam Suppository, 5 mg, vaginal</intervention_name>
    <description>Compounded diazepam 5 mg suppository administered vaginally</description>
    <arm_group_label>Diazepam Suppository, 5 mg, Vaginal</arm_group_label>
    <arm_group_label>Diazepam Tablet, 5 Mg, Oral</arm_group_label>
    <other_name>Valium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam Cream, 5 mg, Vaginal</intervention_name>
    <description>Compounded diazepam cream, 5 mg, inserted vaginally</description>
    <arm_group_label>Diazepam Cream, 5 mg, Vaginal</arm_group_label>
    <arm_group_label>Diazepam Tablet, 5 Mg, Oral</arm_group_label>
    <other_name>Valium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provide informed consent

          -  Premenopausal women &gt; age 18

          -  Able to provide urine and serum samples during the time period

        Exclusion Criteria:

          -  Current use of benzodiazepines in any form. If history of benzodiazepine use, must not
             have taken for one week prior to study screening and enrollment

          -  Pregnancy

          -  Concomitant use of any narcotic drug, ethanol, or any illicit drug use during the
             study period that could be deemed unsafe in combination with benzodiazepine medication
             use as judged by the investigators.

          -  Any evidence of vaginitis on wet mount slide

          -  Postmenopausal

          -  Subject with any other vaginal epithelial disorder that could affect absorption of
             medication as deemed by the investigators.

          -  Any indication/condition/medication that the investigators identify as contraindicated
             in conjunction with diazepam.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Gilleran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>William Beaumont Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's Urology Center, William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2012</study_first_submitted>
  <study_first_submitted_qc>September 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2012</study_first_posted>
  <last_update_submitted>December 12, 2014</last_update_submitted>
  <last_update_submitted_qc>December 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>William Beaumont Hospitals</investigator_affiliation>
    <investigator_full_name>Jason Gilleran</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diazepam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

